Working… Menu

MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00072930
Recruitment Status : Completed
First Posted : November 17, 2003
Last Update Posted : January 15, 2008
Information provided by:
MedImmune LLC

No Study Results Posted on for this Study
Recruitment Status : Completed
Estimated Primary Completion Date : April 2007
Actual Study Completion Date : June 2007